Skip to content
Recall Observatory FDA recall evidence

Drug product

Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02

D-0601-2021

May 03, 2021

Class III

Product summary

Firm
Mylan Institutional LLC
Event
Event 87803
Status
Terminated
Classification
Class III
Quantity
2,131 cartons
Official record key
drug-enforcement:D-0601-2021

Official wording

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Code information: Lot #: 200906, Exp. Date February 2022

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect or Missing